Intrathecal liposomal cytarabine plus systemic therapy versus systemic chemotherapy alone for newly diagnosed leptomeningeal metastasis from breast cancer

類似資料

• OS10.4 Intrathecal liposomal cytarabine plus systemic therapy versus systemic chemotherapy alone for leptomeningeal metastasis from breast cancer - a randomized study. Final results
  著者:: Le Rhun, E, 等
  出版事項: (2019)
• CMET-39. INTRA-CSF LIPOSOMAL CYTARABINE PLUS SYSTEMIC THERAPY AS INITIAL TREATMENT OF BREAST CANCER LEPTOMENINGEAL METASTASIS: A RANDOMISED, OPEN-LABEL TRIAL
  著者:: Le Rhun, Emilie, 等
  出版事項: (2018)
• Chemical meningitis related to intra-CSF liposomal cytarabine
  著者:: Durand, Bénédicte, 等
  出版事項: (2017)
• DEPOSEIN—how meaningful was the benefit from intrathecal chemotherapy?
  著者:: Le Rhun, Emilie, 等
  出版事項: (2020)
• BMET-25 RESULTS OF THE INTERIM SAFETY ANALYSIS OF THE DEPOSEIN TRIAL IN LEPTOMENINGEAL METASTASES FROM BREAST CANCER
  著者:: Le Rhun, Emilie, 等
  出版事項: (2015)